Trial intelligence / Profile preview

Memantine in Acute Mania Associated With Bipolar I Disorder

NCT00106405Phase 2Completed

Sponsor
Forest Laboratories
Start
Feb 2005
Primary completion
Nov 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of memantine in bipolar I disorder, sponsored by Forest Laboratories. Started Feb 2005; status: completed.

02

Drugs

memantine
03

Conditions

bipolar I disorder

Beyond the preview

Go deeper on NCT00106405.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00106405.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call